2/4
05:42 pm
dnth
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: CARR EDWARD
Low
Report
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: CARR EDWARD
2/4
05:42 pm
dnth
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Veness Adam M
Low
Report
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Veness Adam M
2/4
05:41 pm
dnth
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Randhawa Simrat
Low
Report
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Randhawa Simrat
2/4
05:40 pm
dnth
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Savitz Ryan
Low
Report
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Savitz Ryan
2/4
05:39 pm
dnth
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Garcia Marino
Low
Report
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Garcia Marino
2/2
06:08 am
dnth
Form EFFECT Dianthus Therapeutics,
Low
Report
Form EFFECT Dianthus Therapeutics,
1/28
04:25 pm
dnth
Form S-3 Dianthus Therapeutics,
Medium
Report
Form S-3 Dianthus Therapeutics,
1/12
09:02 am
dnth
Form 8-K Dianthus Therapeutics, For: Jan 12
Low
Report
Form 8-K Dianthus Therapeutics, For: Jan 12
12/5
08:00 pm
dnth
Form 4 Dianthus Therapeutics, For: Dec 04 Filed by: Savitz Ryan
Low
Report
Form 4 Dianthus Therapeutics, For: Dec 04 Filed by: Savitz Ryan
12/4
04:43 pm
dnth
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Low
Report
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
11/25
09:00 pm
dnth
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Fairmount Funds Management LLC
Low
Report
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Fairmount Funds Management LLC
11/19
09:16 pm
dnth
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Avidity Partners Management LP
Low
Report
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Avidity Partners Management LP
11/14
09:00 pm
dnth
Form 4 Dianthus Therapeutics, For: Nov 13 Filed by: Randhawa Simrat
Low
Report
Form 4 Dianthus Therapeutics, For: Nov 13 Filed by: Randhawa Simrat
11/14
04:53 pm
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Octagon Capital Advisors LP
11/14
04:35 pm
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: BCLS Fund III Investments, LP
Low
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: BCLS Fund III Investments, LP
11/14
04:17 pm
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
04:09 pm
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Vestal Point Capital, LP
Low
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Vestal Point Capital, LP
11/14
08:10 am
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Deep Track Capital, LP
High
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Deep Track Capital, LP